The HSR clearance significantly de-risks the merger timeline. The next catalyst is the July 8 stockholder vote; monitor for any dissident opposition or competing bids. If approved, the stock should converge toward the merger consideration.
Price Chart
Executive Summary
Esperion Therapeutics disclosed that the Hart-Scott-Rodino waiting period for its pending merger with an affiliate of ArchiMed SAS expired on June 15, 2026, removing a key regulatory condition. The special stockholder meeting to vote on the merger is scheduled for July 8, 2026, and the deal remains subject to stockholder approval and other customary closing conditions.
Key Facts
- HSR waiting period for the ArchiMed merger expired on June 15, 2026.
- Special stockholder meeting to vote on the merger is set for July 8, 2026.
- Merger agreement was entered into on May 1, 2026, with Essence Parent Inc. (ArchiMed affiliate).
- Closing remains subject to stockholder adoption and other customary conditions.
Financial Impact
Not specified
Risk Factors
- Stockholder approval is not guaranteed; failure to adopt would terminate the deal.
- Other closing conditions (e.g., no material adverse change) could still block completion.
- Potential litigation or regulatory delays beyond HSR.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-074562 |
| Document: 0001104659-26-074562-index-headers.html | 0001104659-26-074562 |
| Document: 0001104659-26-074562-index.html | 0001104659-26-074562 |
| Document: 0001104659-26-074562.txt | 0001104659-26-074562 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Court Ruling | — | awaiting T+5 | — | — |
Aug 13, 2026 7w ago | Institutional Cluster | — | awaiting T+5 | — | — |
Jul 23, 2026 10w ago | 15-12G | — | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 25-NSE | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jul 13, 2026 11w ago | 8-K | $3.19 awaiting T+5 | awaiting T+5 | — | — |
Jun 16, 2026 15w ago | DEFA14A | $3.17 $3.15 | ▼ −0.63% | ▲ +0.41% | — |
Jun 11, 2026 16w ago | Institutional Cluster | $3.15 $3.17 | ▲ +0.63% | ▲ +0.20% | — |
Jun 9, 2026 16w ago | 8-K | $3.14 $3.16 | ▲ +0.64% | ▼ −2.80% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access